Pharmaceutical and life sciences R&D facility investment (annual)

Total capital investment planned or committed to pharmaceutical and life sciences research and development facilities.

Unit million GBP Industry Pharmaceuticals

Records
1
Regions
1
Period
2026–2029
Sources
1
Verification 1 verified data points Updated 17 Sep 2026 Last verified 17 Sep 2026 Next update Sources typically refresh annually

The chart

The figure

One published observation so far. A chart follows as soon as a second period is published.

Pharmaceutical and life sciences R&D facility investment (annual)

United Kingdom, 2026–2029

1 observation
400 million GBP United Kingdom · 2026–2029 · GSK · full record
Source: GSK · CC BY 4.0 · statorigin.org

Every record

All records

1 record · 1 region · 2026–2029

Pharmaceutical and life sciences R&D facility investment (annual): every record, grouped by region, newest first.
Period Value Source Type
United Kingdom 1 record
2026–2029 400 million GBP GSK · 28 Jul 2029 forecast

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Pharmaceutical and life sciences R&D facility investment (annual). Retrieved from https://statorigin.org/indicators/pharmaceutical-and-life-sciences-r-d-facility-investment-annual